Mirabella Financial Services LLP Acquires 5,681 Shares of Stryker Corporation $SYK

Mirabella Financial Services LLP boosted its stake in shares of Stryker Corporation (NYSE:SYK) by 124.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 10,248 shares of the medical technology company’s stock after buying an additional 5,681 shares during the period. Mirabella Financial Services LLP’s holdings in Stryker were worth $3,781,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in SYK. Norges Bank acquired a new stake in shares of Stryker in the 2nd quarter valued at about $1,882,173,000. Alliancebernstein L.P. boosted its position in shares of Stryker by 307.6% during the second quarter. Alliancebernstein L.P. now owns 5,596,508 shares of the medical technology company’s stock worth $2,214,146,000 after buying an additional 4,223,366 shares during the period. Corient Private Wealth LLC raised its position in Stryker by 104.4% in the 2nd quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock valued at $887,525,000 after buying an additional 1,146,998 shares during the last quarter. Strive Asset Management LLC acquired a new stake in Stryker in the 3rd quarter valued at approximately $227,389,000. Finally, Credit Agricole S A bought a new stake in Stryker in the 3rd quarter valued at approximately $194,045,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Activity

In other news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the sale, the director directly owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 5.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. BTIG Research raised their price target on shares of Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. William Blair restated an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Piper Sandler reissued an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Finally, UBS Group increased their price objective on shares of Stryker from $386.00 to $400.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 24th. Fourteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $428.61.

Stryker Price Performance

Shares of SYK opened at $349.89 on Tuesday. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The company’s fifty day simple moving average is $365.22 and its 200 day simple moving average is $367.06. Stryker Corporation has a 1-year low of $328.23 and a 1-year high of $404.87. The company has a market cap of $133.90 billion, a price-to-earnings ratio of 41.65, a PEG ratio of 1.97 and a beta of 0.85.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The company’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the firm posted $4.01 EPS. On average, research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be paid a $0.88 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker’s dividend payout ratio is currently 41.90%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.